Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants
Amir Vahedian‐Azimi, Sajad Shojaie, Maciej Banach, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 1228-1243
Open Access | Times Cited: 20

Showing 20 citing articles:

PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 6, pp. 1447-1547
Open Access | Times Cited: 132
Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications
Massimiliano Ruscica, Nicola Ferri, Maciej Banach, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 17, pp. 3288-3304
Open Access | Times Cited: 102
Antioxidant Effects of Statins by Modulating Nrf2 and Nrf2/HO-1 Signaling in Different Diseases
Atena Mansouri, Željko Reiner, Massimiliano Ruscica, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1313-1313
Open Access | Times Cited: 92
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper fromthe International Lipid Expert Panel(ILEP)
Peter E. Penson, Éric Bruckert, David Marais, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 3, pp. 1596-1622
Open Access | Times Cited: 56
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials
Ulrich Laufs, Christie M. Ballantyne, Maciej Banach, et al.
Journal of clinical lipidology (2022) Vol. 16, Iss. 3, pp. 286-297
Open Access | Times Cited: 30
Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma
Yuan-dong Sun, Hao Zhang, Yuanmin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189086-189086
Closed Access | Times Cited: 7
Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma
Jiao Wang, Chengyu Liu, Rong‐Hua Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Do Statins Affect Viral Infections Encountered by International Travelers?
Chinmay Jani, Christian Mouchati, Nour Abdallah, et al.
Tropical Medicine and Infectious Disease (2025) Vol. 10, Iss. 3, pp. 73-73
Open Access
Statins exposure and adverse events in participants with chronic viral hepatitis: a meta-analysis based on cohort studies
J. Ibáñez Ruán, Yingying Fang, Xingfen Zhang, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access
Circulating citrate as a mediator in the relationship between HMGCR inhibitors and chronic hepatitis B: a Mendelian randomization study
Lili Zhang, Yuming Li, Ying Li
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
2021 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Diagnostyka Laboratoryjna (2021) Vol. 57, Iss. 1, pp. 1-99
Closed Access | Times Cited: 24
Comparison of statins with steroids and botulinum toxin A in the prevention of benign strictures after esophageal endoscopic submucosal dissection: a retrospective cohort study
Yanjuan Wang, Weiyu Xia, Tian Li, et al.
Surgical Endoscopy (2023) Vol. 37, Iss. 6, pp. 4328-4337
Closed Access | Times Cited: 6
Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems
Maciej Banach, Giuseppe Danilo Norata
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 879-888
Open Access | Times Cited: 6
The effect of statins on the risk of anti-tuberculosis drug-induced liver injury among patients with active tuberculosis: A cohort study
Chun‐Kai Huang, Jei-Yie Huang, Chin-Hao Chang, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 3, pp. 498-508
Open Access | Times Cited: 1
Nutrition in Viral Hepatitis
Dibya Lochan Praharaj, Anil C. Anand
Current Hepatology Reports (2023) Vol. 22, Iss. 1, pp. 9-23
Closed Access | Times Cited: 2
Statin Intolerance: An Overview for Clinicians
Stanisław Surma, Joanna Lewek, Peter E. Penson, et al.
Contemporary diabetes (2023), pp. 597-635
Open Access | Times Cited: 2
Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience
Andrea Dalbeni, Rosanna Villani, Michele Bevilacqua, et al.
Journal of Digestive Diseases (2022) Vol. 23, Iss. 5-6, pp. 324-330
Closed Access | Times Cited: 3
The Role of Statins in Cirrhosis
Carlos Moctezuma‐Velázquez, Juan G. Abraldeṣ
Current Treatment Options in Gastroenterology (2022) Vol. 20, Iss. 3, pp. 316-335
Closed Access | Times Cited: 3
Impact of statins in the liver: A bane or a boon?
George Sarin Zacharia, Anu Jacob, Manivarnan Karichery, et al.
Canadian Liver Journal (2024)
Closed Access
LipoCol Forte capsules reduce the risk of liver cancer: A propensity score-matched, nationwide, population-based cohort study
Hsiang-Chun Lai, Hung‐Jen Lin, Ying‐Hsiu Shih, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 5, pp. 828-842
Open Access
Page 1

Scroll to top